RSV and non-RSV illness hospitalization in RSV immunoprophylaxis recipients: A systematic literature review-Reference-Cited by-同舟云学术

RSV and non-RSV illness hospitalization in RSV immunoprophylaxis recipients: A systematic literature review

Published:2020-08 Issue: Volume:129 Page:104339
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Bloomfield Adam,DeVincenzo John P.,Ambrose Christopher S.,Krilov Leonard R.

Funder

AstraZeneca

Sobi, Inc

The Lockwood Group

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference38 articles.

1. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006;Stockman;Pediatr. Infect. Dis. J.,2012

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

3. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid;Boyce;J. Pediatr.,2000

4. Respiratory syncytial virus and premature infants born at 32 weeks’ gestation or earlier: hospitalization and economic implications of prophylaxis;Stevens;Arch. Pediatr. Adolesc. Med.,2000

5. Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-25 weeks gestation not receiving immunoprophylaxis;Ambrose;Pediatr. Infect. Dis. J.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024);Vaccines;2024-06-08

2. RSV Infection in Refugees and Asylum Seekers: A Systematic Review and Meta-Analysis;Epidemiologia;2024-05-27

3. Innate Lymphoid Cells and Their Role in the Immune Response to Infections;Cells;2024-02-13

4. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants;Italian Journal of Pediatrics;2023-02-10

5. RSV disease in infants and young children: Can we see a brighter future?;Human Vaccines & Immunotherapeutics;2022-06-20